SCI 6th Annual Securitization Pricing, Investment & Risk Seminar

 


SCI 6th Annual Securitization Pricing, Investment & Risk Seminar, New York, 13th June 2013

 

Sponsored by:

 
              

 

 

 

 

PriceServe
CLO and RMBS Pricing

   

 

 

 

   

Download the conference presentations


Agenda 08:00 REGISTRATION AND BREAKFAST

08:40 INTRODUCTION 08:45 KEYNOTE SPEAKER
Chris Flanagan, Managing Director, Head of U.S. Mortgage and Structured Finance Research, Bank of America Merrill Lynch Bio
Mr Flanagan presents an overview of the current economic environment, and the appetite for, and pricing of new and existing securitizations.

09:30 RELATIVE VALUE OPPORTUNITIES: TRADERS’ ROUNDTABLE
A discussion on relative value opportunities across the secondary markets. Where does value exist across the capital structure, and in which collateral? What opportunity does peripheral debt, particularly in Europe, present for US investors? What issues does the market face in relation to liquidity, transparency and pricing?
Moderator:
John Calabrese, Guggenheim Partners Bio
Panel:
Matt Natcharian, Babson Capital Management Bio
David Trepanier, Bank of America Merrill Lynch Bio
John McElravey, Wells Fargo Bio
Harris Trifon, Deutsche Bank Bio

10.30 Networking Break

10:45 NEW ISSUE MARKET: ARRANGERS’ PANEL
ABS and CLO arrangers discuss pricing, transparency and issuance trends, including the impact of regulatory initiatives on volumes and prices. How is the re-emergence of the private label RMBS market progressing, given the improving housing market and GSE reform? Is the CLO pipeline likely to remain as strong going forward? What are practitioners doing to address negative supply?
Moderator:
Cynthia Sachs, Bloomberg Bio
Panel:
Jason Powers, Wells Fargo Bio
James B. Kane, GreensLedge Capital Markets Bio
Erez Biala, Jefferies & Co Bio

11:45 Two parallel streams to choose from:

Stream 1: MANAGING RISK: BUY-SIDE STRATEGIES
Regulatory and counterparty risk concerns persist for buy-side firms. How are risk managers reacting and who are the innovators in managing and pricing these risks? Many buy side firms choose to co-purchase with a partner when buying bank assets: how is the counterparty chosen and the associated risks calculated?
Moderator:
Marc Alvarez, Interactive Data Bio
Panel Includes:
Takayoshi Wiesner, Mizuho Bio
John Uhlein, Grenadier Capital Bio
Bo Williams, Hildene Capital Management Bio
Adam Dener, Conning Bio

Stream 2: WORKSHOP - THE DEVIL IS IN THE DETAILS : AN IN-DEPTH UNDERSTANDING TO VALUING NON-AGENCY RMBS AND CLOs
The 2013 regulatory environment is putting increased pressure on valuations for structured products, namely Non-Agency RMBS and CLOs. Even the underlying collateral, such as leveraged loans, has gained more attention from the regulators. Not only is the final price under greater scrutiny, financial firms will now be required to defend their pricing methodologies on harder-to-price securities. Join Bloomberg for an in-depth look at relative value models for structured products to provide transparency and defensibility into an evaluated price
Presented by:
David Scalzetti, BVAL Bio 
Jesse Knapp, Kanerai Bio

12.45 Lunch

13:30 SUPPLYING DEMAND: REAL MONEY INVESTOR PANEL
Pension, insurance and investment managers discuss what they want from the securitization markets. What short, medium and long term opportunities are currently attractive to investors and their stakeholders? Is securitization becoming an attractive, mainstream investment once again?
Moderator:
Andrea Pincus, Reed Smith Bio
Panel Includes:
Matthew Wittman, Christofferson Robb Bio
John Di Paolo, Prudential Bio
Thomas Carroll, HSBC Bio
Sameer Tikoo, Partnerre Asset Management Bio  

14.30 Networking Break

14.40 Two parallel streams to choose from:

Stream 1: REGULATIONS, AUDIT AND ACCOUNTING
How can the internal valuation process be improved to get statements across the line with auditors more effectively and efficiently? Which steps can the industry take to better value the more illiquid bonds and stale marks and avoid falling foul of regulators?
Moderator:
Jason Plourde, Grant Thornton Bio
Panel Includes:
Gene Phillips, PF2 Securities Bio
Cynthia Sachs, Bloomberg Bio 
Thomas Phelan, Deloitte Bio
Jackie Gordon, KPMG Bio

Stream 2: WORKSHOP - TECHNIQUES USED IN ANALYZING CASH CLOs
This interactive workshop will include the following topics

  • Fundamental Valuation and Credit Risk
  • Evaluated Market Pricing
  • Data-driven Performance Analysis
    Hosted by
    Luis Amador Bio
    Andrew Jacobs, Moody's Analytics Bio

    15:40 MODEL PRICES VERSUS SECONDARY MARKET PRICES
    How do evaluated price vendors help users understand their methodologies and hence supply a reliable valuation? Which steps can the industry take to better value the more illiquid bonds and stale marks?
    Moderator:
    Paolo Josca, Duff & Phelps Bio
    Panel:
    Ajit Gupta, Bank of America Merrill Lynch Bio
    Ron D'Vari, New Oak Capital Bio
    Richard Cooperstein, Rangemark Bio
    David Kurnov, Moody's Analytics Bio
    Kenneth Lee, Interactive Data Bio


    16:30 Close 

    For information on exhibiting or speaking at this event, please call: +44 20 7061 6335 or 1800 347 0161 or EMAIL SCI.
     

    Delegates registered as of 23 May 2013 include:

    Dhruv Bajpai Angelo Gordon
    Carlos Bonetto Societe Generale
    Ira Braswell Goldman Sachs & Co.
    Brendan Brendan Silvermine Capital
    Jasper Brice HSBC
    Mario Felipe Campuzano Ochoa BroadSouth Investment Management, LLC
    Robert Caruso Direct Access Partners
    Adrienne Cerniglia Hapoalim Securities USA, Inc.
    Keith Chen AIG
    Phoebe Cheng One William Street Capital
    Kuangyu Chin Mizuho Corporate Bank
    Evelyn Cho Christofferson, Robb & Company
    Matthew Cohen Waterfall Asset Management
    Laura Cohen Angelo, Gordon & Co
    Cathy Cunningham CREMAC Commercial Finance
    JD Diabira Riskmont
    Vincent Dolan BayernLB
    John Duddy Marathon Asset Management
    Cong Fang Mizuho Corporate Bank
    Michael Fellus Braver Stern
    Philip Friedman Philip Friedman
    Rob Goldwasser Bank of New York Mellon
    pat gonzalez Athilon
    Jesse Goodman Morgan Stanley
    Suzanne Grady Federal Reserve Bank of New York
    Pan Gu Mizuho
    Martin Helm Syncope LLC
    Christopher Heron RBC Capital Markets
    Yutaka Hiraoka Mizuho Corporate Bank, Ltd.
    Richard Horton EisnerAmper LLP
    Ferry Jacob RBS
    Vivek Jain Bank of America Merrill Lynch
    PK Jain Braver Stern
    Advait Joshi BNP Paribas
    Caio Kac Itau Unibanco SA - New York Branch
    Julian Kamba LBBW
    Arthur Kavalis Three Court LP
    Asif Khan Storm Harbour Securities
    Sanjeev Khurana Pierpont
    Elizabeth Kim Citi
    Janet Kim Ellington Management Group, LLC
    Elise Kim Napier Park Global Capital
    Jong Kim Amherst Advisory & Management, LLC
    John Kohler Cantor Fitzgerald
    Youriy Koudinov Lewtan Technologies
    David Leff LeffCapital
    Raphael Licht RAIT Financial Trust
    Maggie Liu UBS
    Bob Makarechian Clear Mountain Capital
    Leila Manii DBRS, Inc.
    Fa'iz Marhami Fitch Solutions
    John Mawe Syncora
    Jim McClernan Sovereign Bank
    Joseph Mezyk PNC
    Sandeep Mody Syncope, LLC
    Kevin F. Niblo MAXCOR/ BGC Partners
    Feng Ning Scotiabank
    KANAN PARIKH GE Capital
    Vincent Pini Barclays
    Jackie Polak LBBW
    Joseph Priolo DBRS
    Adrian Radulescu AMR
    Sandra Ramirez Further Lane Asset Management
    Sunil Rohra Moody's
    Bhawandeep Sandha UBS
    John Schiavetta AllianceBernstein
    Eugene Schlanger Standard Chartered
    Lisa Seim Strategic Exchanges Innovative Markets
    Eli Shaashua Red Granite Capital Partners
    Stephen Sharkey Shenkman Capital
    Mickey Shemi Christofferson, Robb & Co.
    Matthew Shepard Lord Abbett & Co.
    Amir Shuja J P MORGAN CHASE
    Kunwar Singh Paulson & Co., Inc.
    Steven Snyder Windham Associates
    Alvar Soosaar Taberna Capital
    Connie Swart EisnerAmper LLP
    Vincent Tang Nomura
    Alex Tang Citi
    Leon Tatevossian RBC Capital Markets, LLC
    Mustafa Tayeb AVENUE CAPITAL GROUP
    Walt Tsin Seer Capital Management
    Manish Valecha Gapstow Capital Partners
    Amit Valecha UBS
    Susan VanSciver Hapoalim Securities USA, Inc
    Lauren Walsh CBRE Global Investors
    June Wang Bank of America
    Jim Wang Eidesis Capital
    David Weeks Serenitas Capital LP
    Takayoshi Wiesner Mizuho Corporate Bank
    David Williams Natixis
    John Yi THL Credit SLS
    Christine Yom Black Diamond
    Mengdan Yu Citi
    Ronald Yung White, Weld & Co.
    Michael Zoccoli UBS

    Photos from SCI 2012 Pricing Seminar New York
       

     

     




  • back to top